Good morning :)

How to use scorecard? Learn more

AMC Logo

HDFC Pharma and Healthcare Fund(IDCW Reinvest) Direct IDCW

IDCW
₹20.820.65% (-0.14)
High
—
—
Low
—
—
Returns
—
—
Loading...
1M
6M
1Y
3Y
5Y
Max
SIP

Mid-size Fund

Assets Under Mgmt: ₹ 3,501 Cr

Very High Risk

Principle investment will be at very high risk

Scorecard

Performance

High

The creamy layer - amongst the top performing Mutual Funds

Risk

Avg

Average risk vs others in sub-category

Cost

High

Higher costs on pocket vs others

Composition

Avg

Average allocation strategy, nothing exciting

Red flags

Low

We got you covered, no major red flags identified

How to use scorecard? Learn more

Mid-size Fund

Assets Under Mgmt: ₹ 3,501 Cr

Very High Risk

Principle investment will be at very high risk

HDFC Pharma and Healthcare Fund(IDCW Reinvest) Performance & Key Metrics

HDFC Pharma and Healthcare Fund(IDCW Reinvest) Performance & Key Metrics

No LabelNo LabelBase Expense RatioBase Exp. RatioNo LabelNo Label
1.030.710.97
No LabelNo LabelNo LabelNo LabelNo LabelNo Label
1.73-0.1248.82

HDFC Pharma and Healthcare Fund(IDCW Reinvest) Scheme InfoHDFC Pharma and Healthcare Fund(IDCW Reinvest) Scheme Info

PlanPlanLock inLock in
Lock in Period

Period before which your investment can't be withdrawn from the MF scheme

Exit LoadExit Load
Exit Load

The fee that the AMC charges investors at the time of exiting or redeeming their fund units.

IDCW0 yrs1.00%
1% on or before 30D Nil after 30D
SIP Inv.SIP Inv.
Sip Investment

If SIP investments are allowed in the fund or not

Min. LumpsumMin. Lumpsum
Minimum Lumpsum Inv Amount

Minimum investment the AMC allows in the given scheme via lumpsum route

Allowed₹ 100
Initial: ₹ 100 Incremental: ₹ 100
BenchmarkBenchmark
Benchmark Index

Benchmark index wrt which performance of the fund is tracked

BSE Health Care - TRI

About Sectoral Fund - Pharma & Health Care

About Sectoral Fund - Pharma & Health Care

Sectoral Funds - Pharma & Health Care are equity schemes that majorly invest in healthcare sector companies. It will give exposure to entire healthcare sector which comprised a wide range of companies involved in medical services, medical equipments, drugs and medical insurance.

HDFC Pharma and Healthcare Fund(IDCW Reinvest) Peers

HDFC Pharma and Healthcare Fund(IDCW Reinvest) Peers & Comparison

Comparing 3 mutual funds from 
EquitySectoral Fund - Pharma & Health Care
Loading...
Mutual Fund1Y Returns1Y Returns3Y CAGR3Y CAGRLife CAGRLife CAGR
HDFC Pharma and Healthcare Fund(IDCW Reinvest)16.78%27.82%27.33%
Nippon India Pharma Fund(IDCW)-4.39%7.84%9.38%
ICICI Pru Healthcare Fund-(IDCW-Payout)-6.46%11.28%11.57%
SBI Healthcare Opp Fund(IDCW-Payout)9.32%21.51%15.95%

HDFC Pharma and Healthcare Fund(IDCW Reinvest) Returns Comparison

Compare HDFC Pharma and Healthcare Fund(IDCW Reinvest) with any MF, ETF, stock or index
Compare HDFC Pharma and Healthcare Fund(IDCW Reinvest) with any MF, ETF, stock or index
HDFC Pharma and Healthcare Fund(IDCW Reinvest)
Hmm, looks like data is unavailable here. Please come back after some time
Loading...

HDFC Pharma and Healthcare Fund(IDCW Reinvest) Portfolio

HDFC Pharma and Healthcare Fund(IDCW Reinvest) Asset Allocation

HDFC Pharma and Healthcare Fund(IDCW Reinvest) Asset Allocation

Actual

Target

Dec 2025

Mar 2026

Jun 2026

Sep 2026

ACTUAL
Cash & EquivalentsEquity3.23%96.77%

Dec 2025

Mar 2026

Jun 2026

Sep 2026

Tickertape Separator

HDFC Pharma and Healthcare Fund(IDCW Reinvest) Sector Distribution

HDFC Pharma and Healthcare Fund(IDCW Reinvest) Sector Distribution

+1 moreCommodities TradingHealth Care Equipment & SuppliesMiscellaneousLabs & Life Sciences ServicesPharmaceuticals-1.44 %1.56 %2.36 %4.67 %22.13 %70.71 %

Dec 2025

Mar 2026

Jun 2026

Sep 2026

Tickertape Separator

HDFC Pharma and Healthcare Fund(IDCW Reinvest) Sector Weightage

HDFC Pharma and Healthcare Fund(IDCW Reinvest) Sector Weightage

Jun 25Sep 25Dec 25Mar 26Jun 26Sep 2676.66%77.10%72.45%70.54%69.64%70.71%
Pharmaceuticals as a % of total holdings for last six quarters
Tickertape Separator

HDFC Pharma and Healthcare Fund(IDCW Reinvest) Current Holdings

HDFC Pharma and Healthcare Fund(IDCW Reinvest) Current Holdings

Equity

Others

Sort holdings
  • Constituent
    Holding Weight
    3M Change

AMC Profile of HDFC Pharma and Healthcare Fund(IDCW Reinvest)

AMC Profile of HDFC Pharma and Healthcare Fund(IDCW Reinvest)

HDFC Asset Management Company, investment manager to HDFC Mutual Fund, is one of the leading AMCs in the country. The company operates as a joint venture between Housing Development Finance Corporation (HDFC) and Standard Life Investments (SLI).

HDFC Asset Management Company, investment manager to HDFC Mutual Fund, is one of the leading AMCs in the country. The company operates as a joint venture between Housing Development Finance Corporation (HDFC) and Standard Life Investments (SLI).

  • No.of Schemes

    90

  • Total AUM

    ₹ 9,18,097.24 Cr.

HDFC Pharma and Healthcare Fund(IDCW Reinvest) Manager Details

HDFC Pharma and Healthcare Fund(IDCW Reinvest) Manager Details

HDFC Pharma and Healthcare Fund(IDCW Reinvest) Manager Profile

HDFC Pharma and Healthcare Fund(IDCW Reinvest) Manager Profile

Qualification

PGDM - IMT, B.E. (Civil), CFA (USA)

Past Experience

Over 7 years of experience in equity research and 2 years in financial advisory.

Funds Managed (4)
1Y Returns
5.21%
5.21%
3Y CAGR
5.35%
5.35%
Base Exp. Ratio
1.19%
1.19%
1Y Returns
5.21%
5.21%
3Y CAGR
5.35%
5.35%
Base Exp. Ratio
1.19%
1.19%
1Y Returns
16.78%
16.78%
3Y CAGR
27.82%
27.82%
Base Exp. Ratio
0.71%
0.71%
1Y Returns
16.78%
16.78%
3Y CAGR
27.82%
27.82%
Base Exp. Ratio
0.71%
0.71%

HDFC Pharma and Healthcare Fund(IDCW Reinvest) Manager Performance (0)

HDFC Pharma and Healthcare Fund(IDCW Reinvest) Manager Performance (0)

Loading...

HDFC Pharma and Healthcare Fund(IDCW Reinvest) Review & Opinions

HDFC Pharma and Healthcare Fund(IDCW Reinvest) Review & Opinions

The content here in the form of articles and videos is for information purposes only and may have been sourced from publicly available sources or otherwise. Tickertape does not guarantee the authenticity and veracity of the material shared. The User understands and agrees that Tickertape is not aware nor liable for any content shared here.

Frequently asked questions

  1. The current NAV of HDFC Pharma and Healthcare Fund(IDCW Reinvest) is ₹20.82, as of 22nd October 2026.

  2. The HDFC Pharma and Healthcare Fund(IDCW Reinvest) was launched on 1st January 1970. This mutual fund's past returns are as follows:
    • 1 Year Returns: 16.78%
    • 3 Year Returns: 27.82%

  3. The top sectors HDFC Pharma and Healthcare Fund(IDCW Reinvest) has invested in are as follows:
    • Pharmaceuticals | 70.71%
    • Labs & Life Sciences Services | 22.13%
    • Miscellaneous | 4.67%
    • Health Care Equipment & Supplies | 2.36%
    • Commodities Trading | 1.56%
    This data is as on 22nd October 2026.

  4. The top 5 holdings for HDFC Pharma and Healthcare Fund(IDCW Reinvest) are as follows:
    • Divi's Laboratories Ltd | 9.39%
    • Sun Pharmaceutical Industries Limited | 8.28%
    • TREPS - Tri-party Repo | 4.67%
    • Alkem Laboratories Ltd | 4.64%
    • Cipla Ltd | 4.15%
    This data is as on 22nd October 2026.

  5. The asset allocation for HDFC Pharma and Healthcare Fund(IDCW Reinvest) is as follows:
    • Equity | 96.77%
    • Cash & Equivalents | 3.23%
    This data is as on 22nd October 2026.

  6. The AUM (i.e. assets under management) of HDFC Pharma and Healthcare Fund(IDCW Reinvest) is ₹3501.37 Cr as of 22nd October 2026.

  7. The base expense ratio of HDFC Pharma and Healthcare Fund(IDCW Reinvest) Plan is 0.71 as of 22nd October 2026.

  8. The alpha ratio for the HDFC Pharma and Healthcare Fund(IDCW Reinvest) is 9.08

    Alpha is the excess return of a fund compared to its expected return, based on its beta and the risk-free rate. Positive alpha indicates that the fund has outperformed its expected return, while negative alpha suggests underperformance.

  9. The volatility or standard deviation for the HDFC Pharma and Healthcare Fund(IDCW Reinvest) is 13.47

    Standard deviation measures the volatility or risk associated with the returns of a mutual fund. A higher standard deviation indicates higher volatility, suggesting that the returns of the mutual fund are more spread out from the average. On the other hand, a lower standard deviation implies lower volatility and a more stable performance.

  10. The Sharpe ratio for the HDFC Pharma and Healthcare Fund(IDCW Reinvest) is 0.97

    The Sharpe ratio is a measure of risk-adjusted return that evaluates the performance of a mutual fund, by adjusting for its risk. Higher Sharpe ratio indicates a better risk-adjusted performance. A positive Sharpe ratio indicates that the MF has provided a return in excess of the risk-free rate for the amount of risk taken. Conversely, a negative Sharpe ratio suggests that the MF did not adequately compensate for the risk.

  11. The Sortino Ratio for the HDFC Pharma and Healthcare Fund(IDCW Reinvest) is 0.10

    The Sortino ratio of a mutual fund is a measure of its risk-adjusted return, considering only downside volatility. It helps investors evaluate how well a fund is performing relative to its downside risk. A higher Sortino ratio (value >1) means the fund generates better returns for the downside risk taken.

  12. The PE ratio of HDFC Pharma and Healthcare Fund(IDCW Reinvest) is 48.82, while category PE ratio is 46.56.